These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11314769)

  • 21. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.
    Ito Y; Fujita M; Shimada S; Watanabe Y; Okada T; Kusuoka H; Tohyama M; Nishimura T
    Synapse; 1999 Mar; 31(3):178-85. PubMed ID: 10029235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.
    Kordower JH; Rosenstein JM; Collier TJ; Burke MA; Chen EY; Li JM; Martel L; Levey AE; Mufson EJ; Freeman TB; Olanow CW
    J Comp Neurol; 1996 Jun; 370(2):203-30. PubMed ID: 8808731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss.
    Harvey DC; Lacan G; Tanious SP; Melega WP
    Brain Res; 2000 Jul; 871(2):259-70. PubMed ID: 10899292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
    Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
    Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
    Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure.
    Harvey DC; Laćan G; Melegan WP
    Exp Brain Res; 2000 Aug; 133(3):349-58. PubMed ID: 10958525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease.
    Harrington KA; Augood SJ; Kingsbury AE; Foster OJ; Emson PC
    Brain Res Mol Brain Res; 1996 Feb; 36(1):157-62. PubMed ID: 9011752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
    Moukhles H; Nieoullon A; Daszuta A
    Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
    Roy E; Côté PY; Grégoire L; Parent A; Bédard PJ
    Neuroscience; 1995 May; 66(2):413-25. PubMed ID: 7477882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat.
    Meyer M; Widmer HR; Wagner B; Guzman R; Evtouchenko L; Seiler RW; Spenger C
    Exp Brain Res; 1998 Apr; 119(3):345-55. PubMed ID: 9551835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
    Rehavi M; Goldin M; Roz N; Weizman A
    Brain Res Mol Brain Res; 1998 Jun; 57(1):31-7. PubMed ID: 9630494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions.
    Frohna PA; Neal-Beliveau BS; Joyce JN
    Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
    Mendez I; Baker KA; Hong M
    Brain Res Brain Res Rev; 2000 Apr; 32(1):328-39. PubMed ID: 10751681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine.
    Cenci MA; Björklund A
    Brain Res; 1994 Nov; 665(1):167-74. PubMed ID: 7882012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery.
    Nikkhah G; Cunningham MG; McKay R; Björklund A
    J Neurosci; 1995 May; 15(5 Pt 1):3562-70. PubMed ID: 7751930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
    Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
    J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.